Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events

Xiaozhou He1, Harleen K Sandhu, Yilin Yang

  • 1The Third Clinical College of Suzhou University, Changzhou, Jiangsu, China.

Insights

Delta-opioid receptors (DOR) show neuroprotective effects against hypoxic/ischemic brain injury. Targeting DOR offers a promising therapeutic strategy for neurological conditions.

Area of Science:

  • Neuroscience
  • Cellular Biology
  • Pharmacology

Background:

  • Hypoxic/ischemic (HI) injury is a major cause of neurological disability and mortality.
  • Current therapeutic options for HI injury are limited, highlighting the need for novel treatments.
  • Advances in understanding neuronal insult mechanisms have identified opioid receptors, particularly delta-opioid receptors (DOR), as key players.

Purpose of the Study:

  • To investigate the neuroprotective mechanisms of DOR in the context of hypoxic/ischemic brain injury.
  • To explore the potential of DOR as a therapeutic target for neurological disorders.

Main Methods:

  • Review of recent studies on DOR-mediated neuroprotection.
  • Analysis of DOR's role in stabilizing ionic homeostasis, regulating neurotransmitter release, and modulating neuronal signaling.
  • Examination of DOR's impact on antioxidant capacity, apoptosis, and pro-survival pathways.
  • Investigation of DOR's influence on gene/protein expression and endogenous opioid systems.

Main Results:

  • DOR activation confers neuroprotection against HI insults, particularly in the cerebral cortex.
  • Mechanisms include maintaining ionic balance, reducing excitotoxicity, and enhancing cellular defense.
  • DOR signaling modulates apoptotic and pro-survival pathways, regulates gene expression, and influences endogenous opioid release.
  • DOR expression and endogenous opioid release are dynamically regulated by the severity and duration of HI insult.

Conclusions:

  • DOR-mediated neuroprotection is a significant finding with potential clinical applications.
  • Targeting DOR presents a promising therapeutic avenue for treating neurological damage caused by HI injury.
  • Further research into DOR signaling could lead to novel neuroprotective strategies.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Cellular Injury I: Introduction01:00

Cellular Injury I: Introduction

Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...